Op2lysis

2020

MedTech

Op2Lysis develops the first treatment for hemorrhagic stroke a life-threatening disease that affects >1,5M people every year worldwide. Op2lysis program aims at validating the clinical safety and the efficacy of its therapeutic solution to be ready to enter advanced phases of development by 2022.

Op2Lysis is a biotech company dedicated to the development of innovative products to improve the benefit of lytic treatment in stroke, the first cause of acquired handicap worldwide. Christophe GAUDIN and Jérôme PARCQ are the co-founders of Op2Lysis, which benefits from their complementary experiences and skills.

Site web

Other backed projets

Twistiti

Twistiti developed a unique concept that replaces numbers on the watch, which are usually difficult...
Pipaillon

Pipaillon offers a complete range of jams, tapenades, chutneys and candied lemons.The productions ar...
Vestis Labs

Founded by a team of experts with over 15 years of experience in the fashion industry, Vestis Labs w...
Locky

Locky is the mature version of several attempts in the world of bicycle parking. It's a disruptive p...
Imby

At Imby we believe that the health of our pets and the sustainability of our planet, should go hand...
Startup Vie

Startup Vie is a new media dedicated to the world of Belgian startups
Running Care

Running Care is the first health application dedicated to runners, designed 100% by sports doctors.
Revatis

Revatis is a Spin Off of the University of Liege, dedicated to regenerative medicine and cell therap...
CheckHub

CheckHub is a SaaS plugin solution that automates administrative tasks related to people document ma...
Klea

Klea is the first AI powered global legal entity management solution. Use Klea's powerful dashboards...

Other backed projets

Twistiti

Pipaillon

Vestis Labs

Locky

Imby

Startup Vie

Running Care

Revatis

CheckHub

Klea